Table 4.
A comparison of lung side-effects and patient-reported outcome measures.
| PROM | ||||
|---|---|---|---|---|
| Site-Specific Side-Effects | EORTC-QLQ-C30 | EQ-5D-5L | EORTC-QLQ-LC13 | PRO-CTCAE |
| Tiredness | Y | Y | ||
| Hair loss | Y | |||
| Skin reaction | Y | |||
| Skin itching | Y | |||
| Pain or discomfort | Y | Y | Y | Y |
| Nausea | Y | Y | ||
| Vomiting | Y | Y | ||
| Cough | Y | Y | ||
| Shortness of breath | Y | Y | Y | |
| Dysphagia | Y | Y | ||
| Haemoptysis | Y | |||
| Tingling or numbness in arm | Y | Y | ||
| Change in skin colour | Y | |||
C30—General cancer module; EORTC—European Organisation for Research and Treatment of Cancer; EQ—EuroQoL group; LC13—Lung cancer module; PRO-CTCAE—Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events; QLQ—Quality of Life Questionnaire.